Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Scinai Immunotherapeutics Ltd
SCNICurrent price
3.5 USD
-0.09 USD (-2.51%)
Last closed
3.5 USD
Company
–
ISIN
unknown
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
3 036 665 USD
Yield for 12 month
-49.28 %
1Y
3Y
5Y
10Y
15Y
SCNI
Scinai Immunotherapeutics Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases in Israel. It has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was formerly known as BiondVax Pharmaceuticals Ltd. and changed its name to Scinai Immunotherapeutics Ltd. in September 2023. Scinai Immunotherapeutics Ltd. was incorporated in 2003 and is headquartered in Jerusalem, Israel. Address: Jerusalem BioPark, Jerusalem, Israel
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
700 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
+282 964 USD
Last Quarter
–
Current Year
-512 675 USD
Last Year
–
Current Quarter
-657 594 USD
Last Quarter
-157 730 USD
Key Figures SCNI
1 year
3 years
5 years
10 years
EBITDA
-6 999 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-28.35 %
PEG Ratio
–
Return On Equity TTM
–
Wall Street Target Price
700 USD
Revenue TTM
284 000 USD
Book Value
-8.7 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
–
Diluted Eps TTM
–
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
25.9 %
Profit Margin
–
Dividend Analytics SCNI
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History SCNI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:10
Payout Ratio
–
Last Split Date
21.05.2024
Dividend Date
–
Stock Valuation SCNI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
73.1854
Price Sales TTM
10.9628
Enterprise Value EBITDA
-1.519
Price Book MRQ
1.6168
Financials SCNI
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators SCNI
For 52 weeks
2.23 USD
7.6 USD
50 Day MA
3.66 USD
Shares Short Prior Month
20 179
200 Day MA
4.19 USD
Short Ratio
0.21
Shares Short
11 766
Short Percent
5.79 %
BeatStart